No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs533897530 |
chr5:58754389-58754390 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs144502564 |
chr5:58754398-58754399 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs115677946 |
chr5:58754414-58754415 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs549301696 |
chr5:58754423-58754424 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs114091833 |
chr5:58754437-58754438 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs537706424 |
chr5:58754440-58754441 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs570513767 |
chr5:58754452-58754453 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs74559843 |
chr5:58754503-58754504 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs533947856 |
chr5:58754508-58754509 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs17796040 |
chr5:58754510-58754511 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs201953254 |
chr5:58754518-58754519 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs11950805 |
chr5:58754571-58754572 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs543201273 |
chr5:58754602-58754603 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs562901248 |
chr5:58754612-58754613 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs370784525 |
chr5:58754656-58754657 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs142500951 |
chr5:58754662-58754663 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs190026512 |
chr5:58754702-58754703 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs564644501 |
chr5:58754708-58754709 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs150941164 |
chr5:58754772-58754773 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs183777273 |
chr5:58754786-58754787 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs546963472 |
chr5:58754811-58754812 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs551550495 |
chr5:58754822-58754823 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs541673534 |
chr5:58754835-58754836 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs546650166 |
chr5:58754864-58754865 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs34935059 |
chr5:58754865-58754866 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs529563892 |
chr5:58754907-58754908 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs376326997 |
chr5:58754909-58754910 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs560288488 |
chr5:58754946-58754947 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs538380193 |
chr5:58754962-58754963 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs529021521 |
chr5:58754969-58754970 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs115806431 |
chr5:58754993-58754994 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs568910598 |
chr5:58755018-58755019 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs538063134 |
chr5:58755045-58755046 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs377577339 |
chr5:58755053-58755054 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs187598086 |
chr5:58755122-58755123 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs192014888 |
chr5:58755189-58755190 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs533910096 |
chr5:58755211-58755212 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs76142286 |
chr5:58755219-58755220 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs16889865 |
chr5:58755220-58755221 |
Weak transcription Flanking Active TSS Enhancers Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|